These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7033421)

  • 1. Insulin modulation of antibody-dependent cytotoxicity and the detection of antireceptor antibodies.
    Gelfand EW; Ipp MM; Riordan JR
    J Lab Clin Med; 1982 Jan; 99(1):39-45. PubMed ID: 7033421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody-dependent cell-mediated cytotoxic reaction. II. The effect of the concentration of anti-target cell antibodies on the identity of the human effector cells.
    Keaney M; McPhail S; Jodouín CA; Richter M
    Immunology; 1980 Jun; 40(2):205-10. PubMed ID: 7409857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte cytotoxicity: evidence for multiple mechanisms of in vitro erythrocyte target killing. Trypan blue can both inhibit and enhance target lysis.
    Hall RE; Muchmore AV; Blaese RM
    J Reticuloendothel Soc; 1982 Sep; 32(3):233-46. PubMed ID: 7153988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.
    Banerjee D; Fernando L; Sklar S; Richter M
    Immunology; 1981 Sep; 44(1):97-107. PubMed ID: 7275189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.
    Flier JS; Kahn CR; Jarrett DB; Roth J
    J Clin Invest; 1977 Oct; 60(4):784-94. PubMed ID: 893677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R; Hatanaka S; Shoji-Hosaka E; Sakurada M; Kobayashi Y; Uehara A; Yokoi H; Nakamura K; Shitara K
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH; Armstrong E
    Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
    Cortens M; Sklar S; Richter M
    Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
    Keler T; Graziano RF; Mandal A; Wallace PK; Fisher J; Guyre PM; Fanger MW; Deo YM
    Cancer Res; 1997 Sep; 57(18):4008-14. PubMed ID: 9307286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous hypoglycaemia in the presence of both anti-insulin antibody and anti-insulin receptor antibody.
    Bortolotti D; Mothe-Satney I; Ferrari P; Gautier N; Sonke J; Pallé S; Bernard G; Badetti JL; Fredenrich A; Van Obberghen E; Canivet B
    Diabetes Metab; 2006 Dec; 32(6):598-603. PubMed ID: 17296513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysis of antibody coated chicken erythrocytes by a non-lymphocyte pig blood leukocyte.
    Charley B; Salmon H
    Ann Rech Vet; 1980; 11(1):13-20. PubMed ID: 7436327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.
    Deo YM; Sundarapandiyan K; Keler T; Wallace PK; Graziano RF
    J Immunol; 1998 Feb; 160(4):1677-86. PubMed ID: 9469424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
    Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating anti-insulin receptor antibodies in a patient suffering from lupus nephritis and hypoinsulinemic hypoglycaemia.
    Tardella L; Rossetti L; De Pirro R; Camagna A; Leonetti F; Tamburrano G; Merli M; Rossi Fanelli F; Lauro R
    J Clin Lab Immunol; 1983 Nov; 12(3):159-65. PubMed ID: 6663610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioreceptor assay of insulin and detection of anti-insulin receptor antibody using human placenta and their clinical application].
    Kadota S
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):750-61. PubMed ID: 6397418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.